Quick Answer
Structure Therapeutics Inc. reported Total Assets of $1.58 billion for fiscal year 2025.
Structure Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.58B | +75.3% |
| 2024 | $903.33M | +87.4% |
| 2023 | $482.02M | +392.6% |
| 2022 | $97.84M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $832.16M | -10.8% | +1.9% |
| June 30, 2025 | $816.44M | -13.8% | -5.8% |
| March 31, 2025 | $866.55M | +89.5% | -4.1% |
| December 31, 2024 | $903.33M | +87.4% | -3.2% |
| September 30, 2024 | $933.22M | +331.3% | -1.5% |
| June 30, 2024 | $947.03M | +312.8% | +107.1% |
| March 31, 2024 | $457.23M | +84.8% | -5.1% |
| December 31, 2023 | $482.02M | +392.6% | +122.8% |
- Structure Therapeutics Inc. showed an increase of +75.3% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Structure Therapeutics Inc.’s total assets has grown by 1518.8% (from $97.84 million to $1.58 billion).
- The most recent figure is from Structure Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: